Classification of bloodstains deposited at different times on floor tiles using hierarchical modelling and a handheld NIR spectrometer
Literature Information
Aline C. S. Fonseca, José F. Q. Pereira, Ricardo S. Honorato, Rasmus Bro, Maria Fernanda Pimentel
Bloodstains are commonly encountered at crime scenes, especially on floor tiles, and can be deposited over different periods and intervals. Therefore, it is crucial to develop techniques that can accurately identify bloodstains deposited at different times. This study builds upon a previous investigation and aims to enhance the performance of three distinct hierarchical models (HMs) designed to differentiate and identify stains of human blood (HB), animal blood (AB), and common false positives (CFPs) on nine different types of floor tiles. Soft Independent Modeling Class Analogies (SIMCA), and Partial Least Squares-Discriminant Analysis (PLS-DA) were employed as decision rules in this process. The originally published model was constructed using a training set that included samples with a known time of deposit of six days. This model was then tested to predict samples with various deposition times, including human blood samples aged for 0, 1, 9, 20, 30, and 162 days, as well as animal blood samples aged for 0, 1, 10, 13, 20, 29, 105, and 176 days. To improve the identification of human blood, the models were modified by adding zero-day and one-day-old bloodstains to the original training set. All models showed improvement when fresher samples were included in the training set. The best results were achieved with the hierarchical model that used partial least squares-discriminant analysis as the second decision rule and incorporated one-day-old samples in the training set. This model yielded sensitivity values above 0.92 and specificity values above 0.7 for samples aged between zero and 30 days.
Related Literature
Why aggregated carbon nanotubes exhibit low quantum efficiency
Yu-Hsien Lin, Yao-Cheng Lai, Ching-Tung Hsu, Chia-Jung Hu, Wen-Kuang Hsu
DOI: 10.1039/C0CP02691C
Monomer, clusters, liquid: an integrated spectroscopic study of methanol condensation
Hartawan Laksmono, Shinobu Tanimura, Heather C. Allen, Gerald Wilemski, Mark S. Zahniser, Joanne H. Shorter, David D. Nelson, J. Barry McManus
DOI: 10.1039/C0CP02485F
Ultrafast carotenoid band shifts correlated with Chlz excited states in the photosystem II reaction center: are the carotenoids involved in energy transfer?
Elisabet Romero, Ivo H. M. van Stokkum, Jan P. Dekker, Rienk van Grondelle
DOI: 10.1039/C0CP02896G
Low-temperature formation of cubic β-PbF2: precursor-based synthesis and first-principles phase stability study
Christoph Erk, Lukas Hammerschmidt, Dirk Andrae, Beate Paulus, Sabine Schlecht
DOI: 10.1039/C0CP01758B
Determination of coordination modes and estimation of the 31P–31P distances in heterogeneous catalyst by solid state double quantum filtered 31P NMR spectroscopy
Mei-Tao Wang, Qing-Hua Liu, Bing-Wen Hu, Qun Chen, He-Xing Li, Jean-Paul Amoureux
DOI: 10.1039/C0CP01191F
Singlet nuclear magnetic resonance of nearly-equivalent spins
Michael C. D. Tayler, Malcolm H. Levitt
DOI: 10.1039/C0CP02293D
Photoinduced pH drops in water
Matthieu Emond, Jing Sun, Jean Grégoire, Sylvie Maurin, Christophe Tribet, Ludovic Jullien
DOI: 10.1039/C0CP02464C
Beta-amyloid oligomerisation monitored by intrinsic tyrosine fluorescence
Mariana Amaro, David J. S. Birch, Olaf J. Rolinski
DOI: 10.1039/C0CP02652B
Iodobismuthates with N-alkyl- or N,N′-dialkyl-4,4′-bipyridinium: syntheses, structures and dielectric properties
Yang Chen, Zhou Yang, Xin-Yi Wu, Chun-Yan Ni, Zhi-Gang Ren, Hui-Fang Wang
DOI: 10.1039/C0CP02431G
Fabrication of CuInS2 films from electrodeposited Cu/In bilayers: effects of preheat treatment on their structural, photoelectrochemical and solar cell properties
Sun Min Lee, Shigeru Ikeda, Tetsuro Yagi, Takashi Harada, Ahmed Ennaoui, Michio Matsumura
DOI: 10.1039/C0CP02204G
You might also like
How is Ethyl 4-chlorothieno[2,3-b]pyridine-5-carboxylate (CAS: 59713-58-5) typically synthesized?
Ethyl 4-chlorothieno[2,3-b]pyridine-5-carboxylate (CAS: 59713-58-5) can be synth...
What regulatory guidelines apply to 5-Methyl-1H-indole-3-carbaldehyde (CAS: 52562-50-2)?
5-Methyl-1H-indole-3-carbaldehyde (CAS: 52562-50-2) is subject to various regula...
What are the physical and chemical properties of (1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)boronic acid (CAS: 223418-73-3)?
(1,3-Dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-5-pyrimidinyl)boronic acid is a white...
How should waste containing Sulfocostunolide A (CAS: 1016983-51-9) be handled?
Waste containing Sulfocostunolide A (CAS: 1016983-51-9) should be handled with c...
What precautions should be taken when handling Murraxocin (CAS: 88478-44-8)?
When handling Murraxocin (CAS: 88478-44-8), ensure proper personal protective eq...
What are the physical and chemical properties of Formvar (CAS: 63148-64-1)?
Formvar (CAS: 63148-64-1) is an alkyd resin characterized by a high molecular we...
Is (S)-4-benzyl-2-((benzyloxy)methyl)morpholine (CAS: 205242-66-6) safe?
(S)-4-benzyl-2-((benzyloxy)methyl)morpholine is generally safe when handled with...
What industries use Methyl 1-(5-bromo-2-pyrimidinyl)cyclopropanecarboxylate (CAS: 1447607-69-3)?
Methyl 1-(5-bromo-2-pyrimidinyl)cyclopropanecarboxylate (CAS: 1447607-69-3) is p...
Is 2-Methyl-1-phenyl-1-propanamine hydrochloride (CAS: 24290-47-9) safe?
2-Methyl-1-phenyl-1-propanamine hydrochloride (CAS: 24290-47-9) is generally con...
How is 3-(4-Bromophenyl)-2-methylpropanoic acid (CAS: 66735-01-1) typically synthesized?
3-(4-Bromophenyl)-2-methylpropanoic acid is synthesized through a multi-step pro...
Source Journal
Analytical Methods

Analytical Methods welcomes early applications of new analytical and bioanalytical methods and technology demonstrating the potential for societal impact. We require that methods and technology reported in the journal are sufficiently innovative, robust, accurate, and compared to other available methods for the intended application. Developments with interdisciplinary approaches are particularly welcome. Systems should be proven with suitably complex and analytically challenging samples. We encourage developments within, but not limited to, the following technologies and applications: global health, point-of-care and molecular diagnostics biosensors and bioengineering drug development and pharmaceutical analysis applied microfluidics and nanotechnology omics studies, such as proteomics, metabolomics or glycomics environmental, agricultural and food science neuroscience biochemical and clinical analysis forensic analysis industrial process and method development














